Mithramycin for Lung, Esophagus, and Other Chest Cancers
A phase 2 trial of Plicamycin in Lung cancer, Oesophageal cancer, Mesothelioma and Breast cancer, run by National Cancer Institute (NCI), recorded as terminated on the registry.
Overview
Mithramycin for Lung, Esophagus, and Other Chest Cancers is a phase 2 interventional study registered as NCT01624090 by National Cancer Institute (NCI), with 16 participants recorded, started 2012-09-06 and due to reach its primary completion in 2019-08-20. Interventions recorded: Mithramycin. Conditions recorded: Lung Cancer, Esophageal Cancer, Mesothelioma, Gastrointestinal Neoplasms, Breast Cancer.
Linked to the drug Plicamycin because the registry names it among its interventions and Lung cancer, Oesophageal cancer, Mesothelioma and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
Shares Lung cancer (all types) and the tag pipeline.
- TrialDocetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Shares Lung cancer (all types) and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialStudy of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Shares Mesothelioma and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.